RIFAMPIN

Course overview

RIFAMPIN IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF VARIOUS MYCOBACTERIAL AND GRAM-POSITIVE BACTERIAL INFECTIONS. IT BELONGS TO THE ANTIMICROBIAL CLASS OF DRUGS. THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR RIFAMPIN AS A VALUABLE AGENT IN MANAGING TUBERCULOSIS, LEPROSY, AND SERIOUS GRAM-POSITIVE INFECTIONS, INCLUDING MRSA. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, AND RELEVANT INTERACTIONS) PERTINENT TO MEMBERS OF THE HEALTHCARE TEAM IN THE MANAGEMENT OF PATIENTS WITH TUBERCULOSIS AND RELATED CONDITIONS.